WASHINGTON, D.C. — August 25, 2016 — The Sabin Vaccine Institute announced today that it has received an award of US$468,328 from the U.S. Centers for Disease Control and Prevention (CDC) to support initiatives to improve sustainable immunization financing. The project, conducted in partnership with the Pan American Health Organization (PAHO), will support sustainable financing, planning and decision-making for immunization programs in low- and middle-income countries. The program will launch in the Democratic Republic of Congo, Senegal and Kenya in 2016.
Statements and Press Releases
KATHMANDU, NEPAL — July 19, 2016 — The Sabin Vaccine Institute’s Sustainable Immunization Financing (SIF) Program today assembled senior officials from 21 countries to share their successes in increasing government budget allocations for national immunization programs. Greater political commitment and advocacy are building the momentum needed for countries to fully finance their immunization programs by 2020 and achieve the goals set forth in the Global Vaccine Action Plan (GVAP).
KAMPALA, UGANDA — April 28, 2016 — The Sabin Vaccine Institute (Sabin) applauds the enactment of Uganda’s Immunization Act, 2016, which was recently signed into law by President Yoweri Museveni.
WASHINGTON, D.C. — April 19, 2016 — The Sabin Vaccine Institute (Sabin) will present the 2016 Albert B. Sabin Gold Medal Award to George R. Siber, M.D., chief scientific officer of ClearPath Vaccines Company.